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Background
Antibodies to HIV envelope glycoproteins, with or without
neutralization when assayed in standard neutralization
assays, are reported to have potential to exert either inhibi-
tory or enhancing effects through interactions with com-
plement and/or Fc receptors. Although most of the
standard neutralization assays use free virus rather than
carrier-bound HIV as the infectious agent; a cell line as
the target for infection; and no complement (C), these
conditions may not reflect in vivo events that would
include antibody-dependent innate effector mechanisms.
Methods
We investigated the Fc-receptor-mediated and the com-
plement-mediated antibody-dependent enhancement in
trans infection neutralization assays using two broadly
neutralizing monoclonal antibodies, 4E10 and b12; pri-
mary HIV; PBMC target cells naturally expressing Fc
receptors and complement receptors; and with or without
complement.
Results
In the absence of complement, the 4E10 mAb did not
neutralize erythrocyte-bound HIV, and the b12 mAb
neutralized erythrocyte-bound HIV less effective than the
free virus. At low concentrations, 4E10 caused enhance-
ment of infection. In contrast, in the presence of comple-
ment, 4E10 neutralized erythrocyte-bound HIV, or
caused enhancement of trans infection of erythrocyte-
bound HIV, depending on the mechanism of binding of
HIV to erythrocytes.
Conclusion
Our results are consistent with the concept that the bind-
ing of HIV to erythrocytes represents a mechanism of
establishing a “safe harbor” for HIV from the adverse
effects of antibodies and complement that might otherwise
be detrimental to free circulating HIV. Our data shows
that broadly neutralizing antibody 4E10 can cause both
C-mediated neutralization and enhancement of trans
infection. This suggests that erythrocyte-bound HIV-1
serves as a sort of battleground between neutralization
and enhancement by antibodies in the presence of C.
Because of this, we propose that induction of neutralizing
vs. enhancing antibodies can only be differentiated by utili-
zation of a trans infection neutralization assay that might
yield more relevant results for in vivo conditions.
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